rotem based transfusion algorithm (Rotem Industries)
86
Structured Review
Rotem Industries
rotem based transfusion algorithm
Rotem Based Transfusion Algorithm, supplied by Rotem Industries, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rotem+based+transfusion+algorithm/algorithms+guided+rotem+transfusion/pmc12597362-270-196-196
Average 86 stars, based on 1 article reviews
Rotem Based Transfusion Algorithm, supplied by Rotem Industries, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rotem+based+transfusion+algorithm/algorithms+guided+rotem+transfusion/pmc12597362-270-196-196
Average 86 stars, based on 1 article reviews
rotem based transfusion algorithm - by Bioz Stars,
2026-11
86/100 stars
Images
Related Articles
Control:Article Title: Use of prothrombin complex concentrates in liver transplantation: a systematic review and meta-analysis Article Snippet: Hartmann and colleagues 35 (2019) (Germany) , Retrospective cohort , 372 , Patients undergoing deceased donor LT , Factor concentrate eligible group consistent of patients managed using a ROTEM-based algorithm that included factor concentrates. FC was administered in 187 (50%) patients (range 1–22 g); PCC (CSL Behring) was administered in 70 (19%) patients (range 1000–7000 U) , Multivariate logistic regression used including administration of FC, PCC, RBC concentrates, platelet concentrates, infused and transfused volume as a surrogate of blood loss, tranexamic acid use, and MELD score , Standardised ROTEM-guided transfusion algorithm including factor concentrates and not plasma, with EXTEM, INTEM, FIBTEM, and APTEM (for fibrinolysis detection) available, done at: (1) baseline at the beginning of surgery; (2) anhepatic phase; (3) after reperfusion; (4) end of procedure; (5) at discretion of anaesthesiologist , Intraoperative cell salvage was used in all patients without cancer. Tranexamic acid administration was guided by a standardised algorithm, and was administered to 91 (24%) with evidence of hyperfibrinolysis. The most common dose was 2 g.. .. Nascimento and colleagues 36 (2020) (Brazil) , Mixed retrospective ( n =82) and prospective ( n =71) , 153 82 patients evaluated using a Coagulation:Article Title: Use of prothrombin complex concentrates in liver transplantation: a systematic review and meta-analysis Article Snippet: Hartmann and colleagues 35 (2019) (Germany) , Retrospective cohort , 372 , Patients undergoing deceased donor LT , Factor concentrate eligible group consistent of patients managed using a ROTEM-based algorithm that included factor concentrates. FC was administered in 187 (50%) patients (range 1–22 g); PCC (CSL Behring) was administered in 70 (19%) patients (range 1000–7000 U) , Multivariate logistic regression used including administration of FC, PCC, RBC concentrates, platelet concentrates, infused and transfused volume as a surrogate of blood loss, tranexamic acid use, and MELD score , Standardised ROTEM-guided transfusion algorithm including factor concentrates and not plasma, with EXTEM, INTEM, FIBTEM, and APTEM (for fibrinolysis detection) available, done at: (1) baseline at the beginning of surgery; (2) anhepatic phase; (3) after reperfusion; (4) end of procedure; (5) at discretion of anaesthesiologist , Intraoperative cell salvage was used in all patients without cancer. Tranexamic acid administration was guided by a standardised algorithm, and was administered to 91 (24%) with evidence of hyperfibrinolysis. The most common dose was 2 g.. .. Nascimento and colleagues 36 (2020) (Brazil) , Mixed retrospective ( n =82) and prospective ( n =71) , 153 82 patients evaluated using a Periodic Counter-current Chromatography:Article Title: Use of prothrombin complex concentrates in liver transplantation: a systematic review and meta-analysis Article Snippet: Hartmann and colleagues 35 (2019) (Germany) , Retrospective cohort , 372 , Patients undergoing deceased donor LT , Factor concentrate eligible group consistent of patients managed using a ROTEM-based algorithm that included factor concentrates. FC was administered in 187 (50%) patients (range 1–22 g); PCC (CSL Behring) was administered in 70 (19%) patients (range 1000–7000 U) , Multivariate logistic regression used including administration of FC, PCC, RBC concentrates, platelet concentrates, infused and transfused volume as a surrogate of blood loss, tranexamic acid use, and MELD score , Standardised ROTEM-guided transfusion algorithm including factor concentrates and not plasma, with EXTEM, INTEM, FIBTEM, and APTEM (for fibrinolysis detection) available, done at: (1) baseline at the beginning of surgery; (2) anhepatic phase; (3) after reperfusion; (4) end of procedure; (5) at discretion of anaesthesiologist , Intraoperative cell salvage was used in all patients without cancer. Tranexamic acid administration was guided by a standardised algorithm, and was administered to 91 (24%) with evidence of hyperfibrinolysis. The most common dose was 2 g.. .. Nascimento and colleagues 36 (2020) (Brazil) , Mixed retrospective ( n =82) and prospective ( n =71) , 153 82 patients evaluated using a FIBTEM Assay:Article Title: Use of prothrombin complex concentrates in liver transplantation: a systematic review and meta-analysis Article Snippet: Hartmann and colleagues 35 (2019) (Germany) , Retrospective cohort , 372 , Patients undergoing deceased donor LT , Factor concentrate eligible group consistent of patients managed using a ROTEM-based algorithm that included factor concentrates. FC was administered in 187 (50%) patients (range 1–22 g); PCC (CSL Behring) was administered in 70 (19%) patients (range 1000–7000 U) , Multivariate logistic regression used including administration of FC, PCC, RBC concentrates, platelet concentrates, infused and transfused volume as a surrogate of blood loss, tranexamic acid use, and MELD score , Standardised ROTEM-guided transfusion algorithm including factor concentrates and not plasma, with EXTEM, INTEM, FIBTEM, and APTEM (for fibrinolysis detection) available, done at: (1) baseline at the beginning of surgery; (2) anhepatic phase; (3) after reperfusion; (4) end of procedure; (5) at discretion of anaesthesiologist , Intraoperative cell salvage was used in all patients without cancer. Tranexamic acid administration was guided by a standardised algorithm, and was administered to 91 (24%) with evidence of hyperfibrinolysis. The most common dose was 2 g.. .. Nascimento and colleagues 36 (2020) (Brazil) , Mixed retrospective ( n =82) and prospective ( n =71) , 153 82 patients evaluated using a Infection:Article Title: Use of prothrombin complex concentrates in liver transplantation: a systematic review and meta-analysis Article Snippet: Hartmann and colleagues 35 (2019) (Germany) , Retrospective cohort , 372 , Patients undergoing deceased donor LT , Factor concentrate eligible group consistent of patients managed using a ROTEM-based algorithm that included factor concentrates. FC was administered in 187 (50%) patients (range 1–22 g); PCC (CSL Behring) was administered in 70 (19%) patients (range 1000–7000 U) , Multivariate logistic regression used including administration of FC, PCC, RBC concentrates, platelet concentrates, infused and transfused volume as a surrogate of blood loss, tranexamic acid use, and MELD score , Standardised ROTEM-guided transfusion algorithm including factor concentrates and not plasma, with EXTEM, INTEM, FIBTEM, and APTEM (for fibrinolysis detection) available, done at: (1) baseline at the beginning of surgery; (2) anhepatic phase; (3) after reperfusion; (4) end of procedure; (5) at discretion of anaesthesiologist , Intraoperative cell salvage was used in all patients without cancer. Tranexamic acid administration was guided by a standardised algorithm, and was administered to 91 (24%) with evidence of hyperfibrinolysis. The most common dose was 2 g.. .. Nascimento and colleagues 36 (2020) (Brazil) , Mixed retrospective ( n =82) and prospective ( n =71) , 153 82 patients evaluated using a |
